A compact Cascade–Cas3 system for targeted genome engineering

Makarova, K. S. et al. An updated evolutionary classification of CRISPR–Cas systems. Nat. Rev. Microbiol. 13, 722–736 (2015).

Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 (2007).

Garneau, J. E. et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67–71 (2010).

Barrangou, R. & Doudna, J. A. Applications of CRISPR technologies in research and beyond. Nat. Biotechnol. 34, 933–941 (2016).

Brouns, S. J. J. et al. Small CRISPR RNAs guide antiviral defense in Prokaryotes. Science 321, 960–964 (2008).

Hidalgo-Cantabrana, C. & Barrangou, R. Characterization and applications of Type I CRISPR-Cas systems. Biochem. Soc. Trans. 48, 15–23 (2020).

Sinkunas, T. et al. Cas3 is a single‐stranded DNA nuclease and ATP‐dependent helicase in the CRISPR/Cas immune system. EMBO J. 30, 1335–1342 (2011).

Sinkunas, T. et al. In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J. 32, 385–394 (2013).

Mulepati, S. & Bailey, S. In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target. J. Biol. Chem. 288, 22184–22192 (2013).

Redding, S. et al. Surveillance and processing of foreign DNA by the Escherichia coli CRISPR-Cas system. Cell 163, 854–865 (2015).

Vercoe, R. B. et al. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet. 9, e1003454 (2013).

Gomaa, A. A. et al. Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. mBio 5, e00928–00913 (2014).

Kiro, R., Shitrit, D. & Qimron, U. Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system. RNA Biol. 11, 42–44 (2014).

Li, Y. et al. Harnessing Type I and Type III CRISPR-Cas systems for genome editing. Nucleic Acids Res. 44, e34–e34 (2016).

Pyne, M. E., Bruder, M. R., Moo-Young, M., Chung, D. A. & Chou, C. P. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium. Sci. Rep. 6, 25666 (2016).

Hidalgo-Cantabrana, C., Goh, Y. J., Pan, M., Sanozky-Dawes, R. & Barrangou, R. Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus. Proc. Natl Acad. Sci. USA 116, 15774–15783 (2019).

Hampton, H. G. et al. CRISPR-Cas gene-editing reveals RsmA and RsmC act through FlhDC to repress the SdhE flavinylation factor and control motility and prodigiosin production in Serratia. Microbiology 162, 1047–1058 (2016).

Cheng, F. et al. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon. J. Genet. Genomics Yi Chuan Xue Bao 44, 541–548 (2017).

Cañez, C., Selle, K., Goh, Y. J. & Barrangou, R. Outcomes and characterization of chromosomal self-targeting by native CRISPR-Cas systems in Streptococcus thermophilus. FEMS Microbiol. Lett. 366, fnz105 (2019).

Xu, Z. et al. Native CRISPR-Cas-mediated genome editing enables dissecting and sensitizing clinical multidrug-resistant P. aeruginosa. Cell Rep. 29, 1707–1717.e3 (2019).

Zheng, Y. et al. Characterization and repurposing of the endogenous Type I-F CRISPR-Cas system of Zymomonas mobilis for genome engineering. Nucleic Acids Res. 47, 11461–11475 (2019).

Edgar, R. & Qimron, U. The Escherichia coli CRISPR system protects from λ Lysogenization, Lysogens, and prophage induction. J. Bacteriol. 192, 6291–6294 (2010).

Dolan, A. E. et al. Introducing a spectrum of long-range genomic deletions in human embryonic stem cells using type I CRISPR-Cas. Mol. Cell 74, 936–950.e5 (2019).

Morisaka, H. et al. CRISPR–Cas3 induces broad and unidirectional genome editing in human cells. Nat. Commun. 10, 5302 (2019).

Cameron, P. et al. Harnessing type I CRISPR–Cas systems for genome engineering in human cells. Nat. Biotechnol. 37, 1471–1477 (2019).

Pickar-Oliver, A. et al. Targeted transcriptional modulation with type I CRISPR–Cas systems in human cells. Nat. Biotechnol. 37, 1493–1501 (2019).

Chen, Y. et al. Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells. Nat. Commun. 11, 3136 (2020).

Young, J. K. et al. The repurposing of type I-E CRISPR-Cascade for gene activation in plants. Commun. Biol. 2, 383 (2019).

Nam, K. H. et al. Cas5d protein processes Pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system. Structure 20, 1574–1584 (2012).

Hochstrasser, M. L., Taylor, D. W., Kornfeld, J. E., Nogales, E. & Doudna, J. A. DNA targeting by a minimal CRISPR RNA-guided cascade. Mol. Cell 63, 840–851 (2016).

Marino, N. D. et al. Discovery of widespread type I and type V CRISPR-Cas inhibitors. Science 362, 240–242 (2018).

Turner, K. H., Wessel, A. K., Palmer, G. C., Murray, J. L. & Whiteley, M. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proc. Natl Acad. Sci. USA 112, 4110–4115 (2015).

Selle, K., Klaenhammer, T. R. & Barrangou, R. CRISPR-based screening of genomic island excision events in bacteria. Proc. Natl Acad. Sci. USA 112, 8076–8081 (2015).

Chayot, R., Montagne, B., Mazel, D. & Ricchetti, M. An end-joining repair mechanism in Escherichia coli. Proc. Natl Acad. Sci. USA 107, 2141–2146 (2010).

Lindeberg, M., Cunnac, S. & Collmer, A. Pseudomonas syringae type III effector repertoires: last words in endless arguments. Trends Microbiol. 20, 199–208 (2012).

Kvitko, B. H. et al. Deletions in the repertoire of Pseudomonas syringae pv. tomato DC3000 type III secretion effector genes reveal functional overlap among effectors. PLoS Pathog. 5, e1000388 (2009).

Caliando, B. J. & Voigt, C. A. Targeted DNA degradation using a CRISPR device stably carried in the host genome. Nat. Commun. 6, 6989 (2015).

Bachman, M. A. et al. Genome-wide identification of Klebsiella pneumoniae fitness genes during lung infection. mBio 6, e00775 (2015).

Cady, K. C., Bondy-Denomy, J., Heussler, G. E., Davidson, A. R. & O’Toole, G. A. The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J. Bacteriol. 194, 5728–5738 (2012).

Bondy-Denomy, J., Pawluk, A., Maxwell, K. L. & Davidson, A. R. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493, 429–432 (2013).

Rauch, B. J. et al. Inhibition of CRISPR-Cas9 with bacteriophage proteins. Cell 168, 150–158.e10 (2017).

Stanley, S. Y. et al. Anti-CRISPR-associated proteins are crucial repressors of Anti-CRISPR transcription. Cell 178, 1452–1464.e13 (2019).

Ha, A. D. & Denver, D. R. Comparative genomic analysis of 130 bacteriophages infecting bacteria in the genus Pseudomonas. Front. Microbiol. 9, 1456 (2018).

Pósfai, G. et al. Emergent properties of reduced-genome Escherichia coli. Science 312, 1044–1046 (2006).

Csörgő, B., Nyerges, Á., Pósfai, G. & Fehér, T. System-level genome editing in microbes. Curr. Opin. Microbiol. 33, 113–122 (2016).

Képès, F. et al. The layout of a bacterial genome. FEBS Lett. 586, 2043–2048 (2012).

Cui, L. & Bikard, D. Consequences of Cas9 cleavage in the chromosome of Escherichia coli.Nucleic Acids Res. 44, 4243–4251 (2016).

Bowater, R. & Doherty, A. J. Making ends meet: repairing breaks in bacterial DNA by non-homologous end-joining. PLoS Genet. 2, e8 (2006).

Tuladhar, R. et al. CRISPR–Cas9-based mutagenesis frequently provokes on-target mRNA misregulation. Nat. Commun. 10, 4056 (2019).

Smits, A. H. et al. Biological plasticity rescues target activity in CRISPR knock outs. Nat. Methods 16, 1087–1093 (2019).

Choi, K.-H. et al. A Tn7-based broad-range bacterial cloning and expression system. Nat. Methods 2, 443–448 (2005).

Stover, C. K. et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959–964 (2000).

Choi, K.-H. & Schweizer, H. P. mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat. Protoc. 1, 153–161 (2006).

Buell, C. R. et al. The complete genome sequence of the Arabidopsis and tomato pathogen Pseudomonas syringae pv. tomato DC3000. Proc. Natl Acad. Sci. USA 100, 10181–10186 (2003).

Blattner, F. R. et al. The complete genome sequence of Escherichia coli K-12. Science 277, 1453–1462 (1997).

Broberg, C. A., Wu, W., Cavalcoli, J. D., Miller, V. L. & Bachman, M. A. Complete genome sequence of Klebsiella pneumoniae strain ATCC 43816 KPPR1, a Rifampin-resistant mutant commonly used in animal, genetic, and molecular biology studies. Genome Announc. 2, e00924–14 (2014).

Qiu, D., Damron, F. H., Mima, T., Schweizer, H. P. & Yu, H. D. PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria. Appl. Environ. Microbiol. 74, 7422–7426 (2008).

Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345 (2009).

Meisner, J. & Goldberg, J. B. The Escherichia coli rhaSR-PrhaBAD inducible promoter system allows tightly controlled gene expression over a wide range in Pseudomonas aeruginosa. Appl. Environ. Microbiol. 82, 6715–6727 (2016).

Borges, A. L. et al. Bacteriophage cooperation suppresses CRISPR-Cas3 and Cas9 immunity. Cell 174, 917–925.e10 (2018).

Nyerges, Á. et al. Directed evolution of multiple genomic loci allows the prediction of antibiotic resistance. Proc. Natl Acad. Sci. USA 115, E5726–E5735 (2018).

Huynh, T. V., Dahlbeck, D. & Staskawicz, B. J. Bacterial blight of soybean: regulation of a pathogen gene determining host cultivar specificity. Science 245, 1374–1377 (1989).

Kropinski, A. M. Sequence of the genome of the temperate, serotype-converting, Pseudomonas aeruginosa bacteriophage D3. J. Bacteriol. 182, 6066–6074 (2000).

Budzik, J. M., Rosche, W. A., Rietsch, A. & O’Toole, G. A. Isolation and characterization of a generalized transducing phage for Pseudomonas aeruginosa strains PAO1 and PA14. J. Bacteriol. 186, 3270–3273 (2004).

Alikhan, N.-F., Petty, N. K., Ben Zakour, N. L. & Beatson, S. A. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12, 402 (2011).